Healthpeak Properties vs Kimco Realty
Side-by-side comparison of AI visibility scores, market position, and capabilities
Denver healthcare REIT (NYSE: DOC) $21B combined; Healthpeak + Physicians Realty Trust merger Mar 2024, life science labs (SF/SD/Boston) + 300+ MOBs, competing with Alexandria Real Estate and Ventas.
About
Healthpeak Properties, Inc. is a Denver, Colorado-based healthcare real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: DOC) as an S&P 500 Real Estate component — owning, operating, and developing healthcare-focused real estate including life science laboratory buildings (biopharmaceutical R&D facilities in South San Francisco, San Diego, Boston), medical office buildings (outpatient care facilities adjacent to major hospital campuses), and continuing care retirement communities through approximately 400 employees. In March 2024, Healthpeak Properties (then trading as HCP/PEAK) completed its $21 billion merger of equals with Physicians Realty Trust (DOC — medical office REIT with 300+ medical outpatient buildings in 30+ states) — adopting Physicians Realty Trust's ticker symbol "DOC" and creating a $21 billion combined healthcare REIT with 60+ million square feet of life science labs, 18+ million square feet of medical office, and the most diversified healthcare real estate portfolio among public healthcare REITs. CEO Scott Brinker leads the combined company's strategy of capitalizing on the structural demand drivers for healthcare real estate: life science lab demand driven by NIH funding, private biopharma venture investment, and drug approval tailwinds — and medical office demand driven by the shift of healthcare delivery from hospital inpatient settings to outpatient ambulatory care facilities that require real estate closer to patient populations. Healthpeak's life science portfolio in the three dominant biotech clusters (San Francisco Bay Area, San Diego's Torrey Pines/UTC corridor, Boston's Kendall Square/Route 128 corridor) positions it in the markets where biopharma and biotech tenants require Class A laboratory space for drug discovery and development.
Jericho NY open-air grocery-anchored shopping centers (NYSE: KIM) ~$2.1B FY2024 revenue; 570+ centers in top-20 metros, RPT acquisition 2023, Last Mile mixed-use strategy competing with Regency Centers.
About
Kimco Realty Corporation is a Jericho, New York-based open-air shopping center REIT — publicly traded on the New York Stock Exchange (NYSE: KIM) as an S&P 500 Real Estate component — owning, operating, and developing open-air grocery-anchored and mixed-use shopping centers primarily in the top-20 major metropolitan markets (New York metro, Los Angeles, Miami, Chicago, Philadelphia, Washington DC, Atlanta, San Francisco Bay Area) through approximately 2,000 employees. Kimco Realty owns 570+ open-air shopping centers aggregating 100 million+ square feet of gross leasable area (GLA), with the portfolio anchored by necessity-based tenants (grocery stores, home improvement, pharmacy, discount retail) that generate traffic-driving anchor tenancy for inline small shop tenants. In January 2023, Kimco Realty completed the acquisition of RPT Realty (NYSE: RPT — a Michigan-based open-air shopping center REIT owning 57 shopping centers) for $2.0 billion — expanding Kimco's footprint in Sunbelt markets (Tampa, Orlando, Atlanta, Charlotte) and adding RPT's grocery-anchored portfolio to Kimco's predominantly major-metro coastal centers. CEO Conor Flynn has executed Kimco's "Last Mile" real estate strategy: concentrating the portfolio in high-density urban and first-ring suburban markets where open-air shopping centers serve as the last-mile convenience fulfillment point for consumers combining physical shopping with BOPIS (buy online, pick up in store) — positioning Kimco's shopping centers as logistics infrastructure for omnichannel retail rather than purely experiential retail destinations.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.